Vetoquinol S.A [VETO] vs Ipsen S.A [IPN] Detailed Stock Comparison
Vetoquinol S.A
Euronext
Loading...
Ipsen S.A
Euronext
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Vetoquinol S.A wins in 7 metrics, Ipsen S.A wins in 12 metrics, with 0 ties. Ipsen S.A appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Vetoquinol S.A | Ipsen S.A | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 15.24 | 19.70 | Vetoquinol S.A |
| Price-to-Book Ratio | 1.55 | 2.07 | Vetoquinol S.A |
| Debt-to-Equity Ratio | 3.67 | 22.74 | Vetoquinol S.A |
| PEG Ratio | 2.56 | 10.44 | Vetoquinol S.A |
| EV/EBITDA | 7.16 | 6.17 | Ipsen S.A |
| Profit Margin (TTM) | 10.88% | 11.91% | Ipsen S.A |
| Operating Margin (TTM) | 16.28% | 26.17% | Ipsen S.A |
| EBITDA Margin (TTM) | 16.28% | 26.17% | Ipsen S.A |
| Return on Equity | 10.64% | 10.89% | Ipsen S.A |
| Return on Assets (TTM) | 6.66% | 9.58% | Ipsen S.A |
| Free Cash Flow (TTM) | $68.15M | $133.00M | Ipsen S.A |
| Dividend Yield | 1.27% | 1.38% | Ipsen S.A |
| 1-Year Return | -20.94% | 3.10% | Ipsen S.A |
| Price-to-Sales Ratio (TTM) | 1.66 | 2.37 | Vetoquinol S.A |
| Enterprise Value | $707.82M | $8.22B | Ipsen S.A |
| EV/Revenue Ratio | 1.31 | 2.19 | Vetoquinol S.A |
| Revenue per Share (TTM) | $46 | $45 | Vetoquinol S.A |
| Earnings per Share (Diluted) | $4.98 | $5.37 | Ipsen S.A |
| Beta (Stock Volatility) | 0.75 | 0.18 | Ipsen S.A |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Vetoquinol S.A vs Ipsen S.A Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Vetoquinol S.A | -1.06% | -1.46% | -0.80% | 1.92% | 3.19% | -2.11% |
| Ipsen S.A | -0.19% | 3.00% | 3.00% | 5.14% | -12.94% | -6.01% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Vetoquinol S.A | -20.94% | -39.41% | 2.20% | 100.54% | 227.75% | 227.75% |
| Ipsen S.A | 3.10% | 11.48% | 23.03% | 80.26% | 412.54% | 412.54% |
Performance & Financial Health Analysis: Vetoquinol S.A vs Ipsen S.A
| Metric | VETO | IPN |
|---|---|---|
| Market Information | ||
| Market Cap | €895.57M | €8.91B |
| Market Cap Category | Mid cap | Large cap |
| 10 Day Avg. Volume | 9,763 | 76,431 |
| 90 Day Avg. Volume | 5,032 | 69,317 |
| Last Close | €74.40 | €106.30 |
| 52 Week Range | €63.60 - €98.40 | €87.95 - €125.60 |
| % from 52W High | -24.39% | -15.37% |
| All-Time High | €161.00 (Nov 01, 2021) | €155.95 (Sep 10, 2018) |
| % from All-Time High | -53.79% | -31.84% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.01% | 0.11% |
| Quarterly Earnings Growth | 0.50% | 0.44% |
| Financial Health | ||
| Profit Margin (TTM) | 0.11% | 0.12% |
| Operating Margin (TTM) | 0.16% | 0.26% |
| Return on Equity (TTM) | 0.11% | 0.11% |
| Debt to Equity (MRQ) | 3.67 | 22.74 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | €48.82 | €51.15 |
| Cash per Share (MRQ) | €17.49 | €17.50 |
| Operating Cash Flow (TTM) | €85.83M | €976.20M |
| Levered Free Cash Flow (TTM) | €61.39M | €468.82M |
| Dividends | ||
| Last 12-Month Dividend Yield | 1.27% | 1.38% |
| Last 12-Month Dividend | €0.89 | €1.40 |
Valuation & Enterprise Metrics Analysis: Vetoquinol S.A vs Ipsen S.A
| Metric | VETO | IPN |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 15.24 | 19.70 |
| Forward P/E | 14.19 | 10.44 |
| PEG Ratio | 2.56 | 10.44 |
| Price to Sales (TTM) | 1.66 | 2.37 |
| Price to Book (MRQ) | 1.55 | 2.07 |
| Market Capitalization | ||
| Market Capitalization | €895.57M | €8.91B |
| Enterprise Value | €707.82M | €8.22B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.31 | 2.19 |
| Enterprise to EBITDA | 7.16 | 6.17 |
| Risk & Other Metrics | ||
| Beta | 0.75 | 0.18 |
| Book Value per Share (MRQ) | €48.82 | €51.15 |
Financial Statements Comparison: Vetoquinol S.A vs Ipsen S.A
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | VETO | IPN |
|---|---|---|
| Revenue/Sales | N/A | N/A |
| Cost of Goods Sold | N/A | N/A |
| Gross Profit | N/A | N/A |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | N/A | N/A |
| EBITDA | N/A | N/A |
| Pre-Tax Income | N/A | N/A |
| Income Tax | N/A | N/A |
| Net Income (Profit) | N/A | N/A |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | VETO | IPN |
|---|---|---|
| Cash & Equivalents | €206.33M | €528.40M |
| Total Current Assets | €421.18M | €1.90B |
| Total Current Liabilities | €141.53M | €1.63B |
| Long-Term Debt | €11.22M | €269.70M |
| Total Shareholders Equity | €575.93M | €3.82B |
| Retained Earnings | €58.69M | €644.40M |
| Property, Plant & Equipment | €17.79M | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | VETO | IPN |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | VETO | IPN |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 9,763 | 76,431 |
| Average Daily Volume (90 Day) | 5,032 | 69,317 |
| Shares Outstanding | 11.80M | 82.71M |
| Float Shares | 3.83M | 25.27M |
| % Held by Insiders | 0.67% | 0.57% |
| % Held by Institutions | 0.13% | 0.15% |
Dividend Analysis & Yield Comparison: Vetoquinol S.A vs Ipsen S.A
| Metric | VETO | IPN |
|---|---|---|
| Last 12-Month Dividend | €0.89 | €1.40 |
| Last 12-Month Dividend Yield | 1.27% | 1.38% |
| 3-Year Avg Annual Dividend | €0.85 | €1.27 |
| 3-Year Avg Dividend Yield | 0.99% | 1.14% |
| 3-Year Total Dividends | €2.54 | €3.80 |
| Ex-Dividend Date | Jun 04, 2025 | Jun 04, 2025 |